Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Studies of Risk Factors for Pulmonary-, Liver-, and Cardiovascular Disease in the SCAPIS 2 Stockholm Reexamination

NCT07476703 is registered in ClinicalTrials.gov with Danderyd Hospital as lead sponsor.

NCT NCT07476703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07476703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Studies of Risk Factors for Pulmonary-, Liver-, and Cardiovascular Disease in the SCAPIS 2 Stockholm Reexamination
Lead sponsor
Danderyd Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 8, 2024
Completion date
August 30, 2026
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve diseases, arterial stiffness, blood pressure, coronary artery disease, heart failure, inflammation biomarkers, lipid profile, masld - metabolic dysfunction-associated steatotic liver disease, metabolic associated-dysfunction steatohepatitis (mash), mitral valve stenosis and/or insufficiency, oral microbiota, pulmonary disease, chronic obstructive (copd), steatohepatitis